PHARMACYTE BIOTECH INC (PMCB)       2.75  -0.08 (-2.83%)

2.75  -0.08 (-2.83%)

US71715X2036 - Common Stock - After market: 2.85 +0.1 (+3.64%)

2022
(2022-4-30)
2021
(2021-4-30)
2020
(2020-4-30)
2019
(2019-4-30)
2018
(2018-4-30)
ASSETS
Current Assets
Cash
85.40M2.20M894.86K515.25K1.06M
Receivables
N/AN/AN/AN/AN/A
Inventories
N/AN/AN/AN/AN/A
Other Current Assets
94.17K73.13K142.79K138.15K224.07K
Total Current Assets
85.49M2.28M1.04M653.40K1.28M
 
Non-Current Assets
PPE Net
N/AN/AN/AN/AN/A
Investments And Advances
1.57M1.57M1.57M1.57M1.57M
Intangibles
3.55M3.55M3.55M3.55M3.55M
Other Non-Current Assets
7.69K7.37K7.37K7.37K7.37K
Total Non-Current Assets
5.13M5.13M5.13M5.13M5.13M
 
TOTAL ASSETS
90.62M7.40M6.17M5.78M6.41M
 
LIABILITIES
Current Liabilities
Short Term Debt
0.000.000.000.000.00
Accounts Payable And Accrued Liabilities
205.36K172.26K185.84K121.89K352.62K
Accrued Expenses
499.01K552.52K816.64K620.97K291.55K
Other Current Liabilities
N/AN/AN/AN/AN/A
Total Current Liabilities
704.37K724.78K1.03M742.85K644.17K
 
Non-Current Liabilities
Long Term Debt
0.000.0046.28K0.000.00
Total Non-Current Liabilities
0.000.0046.28K0.000.00
 
TOTAL LIABILITIES
704.37K724.78K1.08M742.85K644.17K
 
SHAREHOLDERS' EQUITY
Additional Paid In Capital
201.58M114.11M108.81M104.97M101.64M
Shares Outstanding
20.72M1.59M1.10M794.62K678.88K
Common Shares
2.07K160.00163.86K118.60K101.33K
Retained Earnings
-111.65M-107.41M-103.86M-100.03M-95.96M
Other Shareholders' Equity
-15.76K-20.38K-21.71K-13.84K-4.71K
Total Shareholders' Equity
89.92M6.68M5.09M5.04M5.77M
 
TOTAL LIABILITIES AND EQUITY
90.62M7.40M6.17M5.78M6.41M
 
Statistics
Debt/Equity
N/AN/A0.01N/AN/A
Current Ratio
121.383.141.010.881.99
Return On Assets (ROA)
-4.68%-47.96%-62.06%-70.34%-106.49%
Return On Equity (ROE)
-4.71%-53.17%-75.20%-80.71%-118.38%

All data in USD

Charts